Christian Storm1, Jens Nee, Mattias Roser, Achim Jörres, Dietrich Hasper. 1. Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. christian.storm@charite.de
Abstract
OBJECTIVE: Therapeutic hypothermia has proved effective in improving outcome in patients after cardiac arrest due to ventricular fibrillation (VF). The benefit in patients with non-VF cardiac arrest is still not defined. METHODS: This prospective observational study was conducted in a university hospital setting with historical controls. Between 2002 and 2010 387 consecutive patients have been admitted to the intensive care unit (ICU) after cardiac arrest (control n=186; hypothermia n=201). Of those, in 175 patients the initial rhythm was identified as non-shockable (asystole, pulseless electrical activity) rhythm (control n=88; hypothermia n=87). Neurological outcome was assessed at ICU discharge according to the Pittsburgh cerebral performance category (CPC). A follow-up was completed for all patients after 90 days, a Kaplan-Meier analysis and Cox regression was performed. RESULTS: Hypothermia treatment was not associated with significantly improved neurological outcome in patients resuscitated from non-VF cardiac arrest (CPC 1-2: hypothermia 27.59% vs control 18.20%, p=0.175). 90-Day Kaplan-Meier analysis revealed no significant benefit for the hypothermia group (log rank test p=0.82), and Cox regression showed no statistically significant improvement. CONCLUSIONS: In this cohort patients undergoing hypothermia treatment after non-shockable cardiac arrest do not benefit significantly concerning neurological outcome. Hypothermia treatment needs to be evaluated in a large multicentre trial of cardiac arrest patients found initially to be in non-shockable rhythms to clarify whether cooling may also be beneficial for other rhythms than VF.
OBJECTIVE: Therapeutic hypothermia has proved effective in improving outcome in patients after cardiac arrest due to ventricular fibrillation (VF). The benefit in patients with non-VF cardiac arrest is still not defined. METHODS: This prospective observational study was conducted in a university hospital setting with historical controls. Between 2002 and 2010 387 consecutive patients have been admitted to the intensive care unit (ICU) after cardiac arrest (control n=186; hypothermia n=201). Of those, in 175 patients the initial rhythm was identified as non-shockable (asystole, pulseless electrical activity) rhythm (control n=88; hypothermia n=87). Neurological outcome was assessed at ICU discharge according to the Pittsburgh cerebral performance category (CPC). A follow-up was completed for all patients after 90 days, a Kaplan-Meier analysis and Cox regression was performed. RESULTS:Hypothermia treatment was not associated with significantly improved neurological outcome in patients resuscitated from non-VF cardiac arrest (CPC 1-2: hypothermia 27.59% vs control 18.20%, p=0.175). 90-Day Kaplan-Meier analysis revealed no significant benefit for the hypothermia group (log rank test p=0.82), and Cox regression showed no statistically significant improvement. CONCLUSIONS: In this cohort patients undergoing hypothermia treatment after non-shockable cardiac arrest do not benefit significantly concerning neurological outcome. Hypothermia treatment needs to be evaluated in a large multicentre trial of cardiac arrestpatients found initially to be in non-shockable rhythms to clarify whether cooling may also be beneficial for other rhythms than VF.
Authors: Romergryko G Geocadin; Eelco Wijdicks; Melissa J Armstrong; Maxwell Damian; Stephan A Mayer; Joseph P Ornato; Alejandro Rabinstein; José I Suarez; Michel T Torbey; Richard M Dubinsky; Jason Lazarou Journal: Neurology Date: 2017-05-10 Impact factor: 9.910
Authors: Jukka Vaahersalo; Pamela Hiltunen; Marjaana Tiainen; Tuomas Oksanen; Kirsi-Maija Kaukonen; Jouni Kurola; Esko Ruokonen; Jyrki Tenhunen; Tero Ala-Kokko; Vesa Lund; Matti Reinikainen; Outi Kiviniemi; Tom Silfvast; Markku Kuisma; Tero Varpula; Ville Pettilä Journal: Intensive Care Med Date: 2013-02-16 Impact factor: 17.440
Authors: Pierre Kory; Mayuko Fukunaga; Joseph P Mathew; Bimaljeet Singh; Lisa Szainwald; Joseph Mosak; Mathew Marks; Dana Berg; Meir Saadia; Annie Katz; Paul H Mayo Journal: Neurocrit Care Date: 2012-06 Impact factor: 3.210
Authors: Shin Ahn; Byung Kook Lee; Chun Song Youn; Youn-Jung Kim; Chang Hwan Sohn; Dong-Woo Seo; Won Young Kim Journal: Intern Emerg Med Date: 2017-04-07 Impact factor: 3.397
Authors: Timothy J Mader; Brian H Nathanson; William E Soares; Ryan A Coute; Bryan F McNally Journal: Ther Hypothermia Temp Manag Date: 2014-03-01 Impact factor: 1.286